The FDA really wants the sickest patients that has are at the end of their ropes to be consistent with what MDACC did in AFM13-104 trial.
ie 1. fail chemo-checkpt 2. fail BV (Adcetris) 3. fail SCT if they got to that stage. 4. and no-ongoing infections
MDACC median prior lines were 7! I can't imagine that many lines of treatment for cancer. These folks have been through the a lot. And some of them dropped out because they can't withstand the commute to cancer center.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.